[
Namita Thapar
]Latest from Namita Thapar
Disagree with LT chairman? Shark Tank alum's work-life balance pitch for the win
Has Larsen & Toubro chairman SN Subrahmanyan's comments on work-life balance upset you? Throwback to Shark Tank fame Namita Thapar's more realistic take
Published on Jan 10, 2025 03:29 PM IST
Namita Thapar critiques corporate culture glorifying 70-hour workweek
Namita Thapar and Anupam Mittal debated work-life balance, with Thapar advocating limits for employees and Mittal stressing relentless effort for success.
Updated on Dec 28, 2024 12:40 PM IST
Mahipal Singh Chouhan
Namita Thapar's post on Emcure IPO listing: ‘Mirza Ghalib sums up my feelings’
Emcure Pharmaceuticals listed at ₹1,325.05, up 31.45 per cent on both the BSE and the NSE on July 10.
Updated on Jul 11, 2024 03:11 PM IST
Namita Thapar may gain ₹127 crore in Emcure Pharma IPO
Through the IPO, Namita Thapar will offload a partial stake of about 12.68 lakh shares under the offer for sale (OFS) component.
Updated on Jul 01, 2024 02:13 PM IST
Emcure Pharma gets Sebi approval for IPO: What we know
The IPO includes fresh equity sale worth ₹800 crore and an OFS of 1.36 crore equity shares by promoters and existing shareholders.
Updated on Jun 20, 2024 02:23 PM IST